Literature DB >> 4027139

The metabolism of 7-ethoxycoumarin in human liver microsomes and the effect of primary biliary cirrhosis: implications for studies of drug metabolism in liver disease.

K W Woodhouse, H C Mitchison, E Mutch, P D Wright, M D Rawlins, O F James.   

Abstract

Using 7-ethoxycoumarin as a probe substrate, microsomal monoxygenase activity has been measured in liver tissue from patients with primary biliary cirrhosis (PBC) of varying histological severity, and in histologically normal control tissue. Interindividual variation in enzyme activity was considerable, and in no histological category was the activity significantly different to control. We conclude that: (a) in PBC, hepatic microsomal monoxygenase activity is determined primarily by factors other than the histological severity of the liver disease, and (b) studies of xenobiotic metabolism in patients with liver disease should specify the nature of the underlying disease process.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027139      PMCID: PMC1400632          DOI: 10.1111/j.1365-2125.1985.tb02801.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  The acute effects of ethanol on acetanilide disposition in normal subjects, and in patients with liver disease.

Authors:  J McKay; M D Rawlings; I Cobden; O F James
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

3.  An improved assay of 7-ethoxycoumarin O-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  W F Greenlee; A Poland
Journal:  J Pharmacol Exp Ther       Date:  1978-06       Impact factor: 4.030

4.  Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes.

Authors:  G C Farrell; W G Cooksley; L W Powell
Journal:  Clin Pharmacol Ther       Date:  1979-10       Impact factor: 6.875

5.  Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens.

Authors:  A R Boobis; M J Brodie; G C Kahn; D R Fletcher; J H Saunders; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

6.  The effect of alcoholic cirrhosis on the activities of microsomal aldrin epoxidase, 7-ethoxycoumarin O-de-ethylase and epoxide hydrolase, and on the concentrations of reduced glutathione in human liver.

Authors:  K W Woodhouse; F M Williams; E Mutch; P Wright; O F James; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

7.  The effect of alcoholic cirrhosis on the two kinetic components (high and low affinity) of the microsomal 0-deethylation of 7-ethoxycoumarin in human liver.

Authors:  K W Woodhouse; F M Williams; E Mutch; P Wright; O F James; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro.

Authors:  M J Brodie; A R Boobis; C J Bulpitt; D S Davies
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  8 in total
  3 in total

1.  A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.

Authors:  Trevor N Johnson; Koen Boussery; Karen Rowland-Yeo; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

2.  Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics Study.

Authors:  Bhagwat Prasad; Deepak Kumar Bhatt; Katherine Johnson; Revathi Chapa; Xiaoyan Chu; Laurent Salphati; Guangqing Xiao; Caroline Lee; Cornelis E C A Hop; Anita Mathias; Yurong Lai; Mingxiang Liao; William G Humphreys; Sean C Kumer; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2018-04-25       Impact factor: 3.922

3.  Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma.

Authors:  Jun Zhou; Qiang Wen; Sai-Fei Li; Yun-Fei Zhang; Na Gao; Xin Tian; Yan Fang; Jie Gao; Ming-Zhu Cui; Xiao-Pei He; Lin-Jing Jia; Han Jin; Hai-Ling Qiao
Journal:  Oncotarget       Date:  2016-08-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.